A detailed history of J.P. Marvel Investment Advisors, LLC transactions in Danaher Corp stock. As of the latest transaction made, J.P. Marvel Investment Advisors, LLC holds 34,285 shares of DHR stock, worth $9.26 Million. This represents 1.41% of its overall portfolio holdings.

Number of Shares
34,285
Previous 34,325 0.12%
Holding current value
$9.26 Million
Previous $8.57 Million 0.06%
% of portfolio
1.41%
Previous 1.48%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$235.51 - $267.98 $9,420 - $10,719
-40 Reduced 0.12%
34,285 $8.57 Million
Q1 2024

May 08, 2024

BUY
$224.58 - $256.19 $706,977 - $806,486
3,148 Added 10.1%
34,325 $8.57 Million
Q4 2023

Feb 13, 2024

SELL
$185.1 - $233.13 $140,676 - $177,178
-760 Reduced 2.38%
31,177 $7.21 Million
Q2 2023

Aug 10, 2023

SELL
$224.99 - $256.14 $13,499 - $15,368
-60 Reduced 0.19%
31,937 $7.66 Million
Q3 2022

Oct 24, 2022

BUY
$247.06 - $1507.4 $1.99 Million - $12.2 Million
8,067 Added 33.71%
31,997 $8.27 Million
Q3 2020

Sep 09, 2021

SELL
$177.16 - $215.33 $23,030 - $27,992
-130 Reduced 0.54%
23,930 $5.15 Million
Q2 2020

Sep 09, 2021

SELL
$128.7 - $176.83 $28,313 - $38,902
-220 Reduced 0.91%
24,060 $4.26 Million
Q1 2020

Sep 09, 2021

BUY
$121.39 - $169.05 $2,427 - $3,381
20 Added 0.08%
24,280 $3.36 Million
Q3 2019

Nov 20, 2019

BUY
$135.4 - $146.47 $9,478 - $10,252
70 Added 0.29%
24,260 $3.5 Million
Q1 2018

May 16, 2018

SELL
$92.16 - $103.8 $10,137 - $11,418
-110 Reduced 0.45%
24,190 $2.37 Million
Q4 2017

Feb 14, 2018

SELL
$85.26 - $94.62 $60,534 - $67,180
-710 Reduced 2.84%
24,300 $2.26 Million
Q3 2017

Nov 13, 2017

SELL
$79.29 - $88.45 $662,864 - $739,442
-8,360 Reduced 25.05%
25,010 $2.15 Million
Q2 2017

Aug 24, 2017

BUY
N/A
33,370
33,370 $2.82 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $197B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track J.P. Marvel Investment Advisors, LLC Portfolio

Follow J.P. Marvel Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J.P. Marvel Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on J.P. Marvel Investment Advisors, LLC with notifications on news.